Effect of Using Educational Robots During Vaccination on Fear and Pain in Children
Launched by BALIKESIR UNIVERSITY · Feb 26, 2025
Trial Information
Current as of July 21, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how educational robots can help reduce fear and pain in children during vaccinations. Many young kids feel scared or uncomfortable when getting shots, and this study aims to see if having a robot present can make the experience easier for them. The trial will focus on 4-year-old children who are receiving a specific vaccine called DaBT-İPA at a primary care center in Balıkesir.
To participate in this study, children must be 4 years old and must visit a family health center in Balıkesir for their vaccination. They also need to be willing to take part in the study. If a child is selected, their experience during the vaccination will be observed to see if the educational robot helps lessen their fear and pain. This may be a great opportunity for families looking to support their child in a more comfortable vaccination experience.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Volunteering to participate in the study
- • The child must be 4 years old
- • Must have come to a primary care center in Balıkesir city center
- • DaBT-İPA vaccination must be administered
- • Vastus Lateralis muscle must be used in vaccination
- Exclusion Criteria:
- • Not volunteering to participate in the study
- • The child is not 4 years old
- • He/she has not come to a family health center in Balıkesir city center
- • DaBT-İPA vaccination is not applied
- • Vastus Lateralis muscle will not be used in vaccination application
About Balikesir University
Balikesir University is a prominent educational institution in Turkey, recognized for its commitment to advancing research and innovation in the medical field. As a clinical trial sponsor, the university leverages its extensive academic resources and expertise to facilitate rigorous and ethical research studies aimed at improving healthcare outcomes. Balikesir University collaborates with a diverse range of stakeholders, including healthcare professionals and industry partners, to drive clinical advancements and contribute to the global body of medical knowledge. Through its dedication to scientific excellence and patient safety, Balikesir University plays a vital role in the development of new therapies and treatment modalities.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported